Published in J Biol Chem on February 13, 2006
Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol (2011) 2.73
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nat Med (2014) 1.58
Three-dimensional regulation of radial glial functions by Lis1-Nde1 and dystrophin glycoprotein complexes. PLoS Biol (2011) 1.53
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol (2007) 1.39
Dystrophin is a microtubule-associated protein. J Cell Biol (2009) 1.38
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice. Mol Ther (2008) 1.34
A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med (2010) 1.33
Functional substitution by TAT-utrophin in dystrophin-deficient mice. PLoS Med (2009) 1.30
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim Biophys Acta (2006) 1.25
Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation. Proc Natl Acad Sci U S A (2010) 1.04
Conformational dynamics of actin: effectors and implications for biological function. Cytoskeleton (Hoboken) (2010) 1.02
Internal deletion compromises the stability of dystrophin. Hum Mol Genet (2011) 1.00
Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner. J Cell Physiol (2009) 1.00
Dystrophin and utrophin have distinct effects on the structural dynamics of actin. Proc Natl Acad Sci U S A (2009) 0.98
Progress in gene therapy of dystrophic heart disease. Gene Ther (2012) 0.96
Large-scale modelling of the divergent spectrin repeats in nesprins: giant modular proteins. PLoS One (2013) 0.95
Differential stabilities of alternative exon-skipped rod motifs of dystrophin. Biochim Biophys Acta (2009) 0.93
Calpain-mediated proteolysis of tropomodulin isoforms leads to thin filament elongation in dystrophic skeletal muscle. Mol Biol Cell (2014) 0.92
Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis. Am J Pathol (2007) 0.92
Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype. PLoS One (2008) 0.90
Imaging adhesion and signaling dynamics in Xenopus laevis growth cones. Dev Neurobiol (2012) 0.88
Cytoskeletal interactions at the nuclear envelope mediated by nesprins. Int J Cell Biol (2012) 0.87
Structural organization of the nine spectrin repeats of Kalirin. Biochemistry (2012) 0.86
Computational study of the human dystrophin repeats: interaction properties and molecular dynamics. PLoS One (2011) 0.86
The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy. FEBS J (2013) 0.85
Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAs. PLoS One (2009) 0.85
The carboxy-terminal third of dystrophin enhances actin binding activity. J Mol Biol (2011) 0.85
Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design. J Mol Biol (2012) 0.84
Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle. J Proteome Res (2012) 0.84
The N-terminal actin-binding tandem calponin-homology (CH) domain of dystrophin is in a closed conformation in solution and when bound to F-actin. Biophys J (2012) 0.84
Identification of new dystroglycan complexes in skeletal muscle. PLoS One (2013) 0.82
Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin. Proteins (2012) 0.79
The ZZ domain of dystrophin in DMD: making sense of missense mutations. Hum Mutat (2013) 0.79
DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations. PLoS One (2015) 0.79
The crystal structures of dystrophin and utrophin spectrin repeats: implications for domain boundaries. PLoS One (2012) 0.79
Electron microscopy and 3D reconstruction reveals filamin Ig domain binding to F-actin. J Mol Biol (2012) 0.79
Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin. Hum Mol Genet (2014) 0.77
Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation. FEBS J (2014) 0.76
Cytoskeletal basis of ion channel function in cardiac muscle. Future Cardiol (2006) 0.76
Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy. Expert Opin Orphan Drugs (2015) 0.75
In vitro stability of therapeutically relevant, internally truncated dystrophins. Skelet Muscle (2015) 0.75
Tissue expression and actin binding of a novel N-terminal utrophin isoform. J Biomed Biotechnol (2011) 0.75
Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. Nature (2012) 2.52
Gamma-actin is required for cytoskeletal maintenance but not development. Proc Natl Acad Sci U S A (2009) 1.74
Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc Natl Acad Sci U S A (2006) 1.68
Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation. Biochem J (2005) 1.56
β-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell (2011) 1.46
Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell (2002) 1.44
Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Dev Cell (2006) 1.43
Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem (2010) 1.43
The actin gene family: function follows isoform. Cytoskeleton (Hoboken) (2010) 1.39
Dystrophin is a microtubule-associated protein. J Cell Biol (2009) 1.38
Functional substitution by TAT-utrophin in dystrophin-deficient mice. PLoS Med (2009) 1.30
β-actin and γ-actin are each dispensable for auditory hair cell development but required for Stereocilia maintenance. PLoS Genet (2010) 1.30
Contributions of the LG modules and furin processing to laminin-2 functions. J Biol Chem (2002) 1.28
Crystal structure and cell surface anchorage sites of laminin alpha1LG4-5. J Biol Chem (2007) 1.27
Molecular dissection of the alpha-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10. J Biol Chem (2003) 1.26
Biology of the striated muscle dystrophin-glycoprotein complex. Int Rev Cytol (2008) 1.25
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun (2013) 1.17
The utrophin actin-binding domain binds F-actin in two different modes: implications for the spectrin superfamily of proteins. J Cell Biol (2002) 1.12
Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. Cytoskeleton (Hoboken) (2010) 1.11
Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet (2002) 1.10
Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation. Proc Natl Acad Sci U S A (2010) 1.04
Identification of spectrin-like repeats required for high affinity utrophin-actin interaction. J Biol Chem (2005) 1.01
Axonal regeneration and neuronal function are preserved in motor neurons lacking ß-actin in vivo. PLoS One (2011) 1.01
Internal deletion compromises the stability of dystrophin. Hum Mol Genet (2011) 1.00
Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin. FASEB J (2009) 0.99
β-Actin and fascin-2 cooperate to maintain stereocilia length. J Neurosci (2013) 0.99
Microtubule binding distinguishes dystrophin from utrophin. Proc Natl Acad Sci U S A (2014) 0.98
Dystrophin and utrophin have distinct effects on the structural dynamics of actin. Proc Natl Acad Sci U S A (2009) 0.98
Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding. J Biol Chem (2003) 0.91
Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype. PLoS One (2008) 0.90
Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. PLoS One (2012) 0.90
TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice. J Appl Physiol (1985) (2011) 0.87
Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11. FEBS Lett (2006) 0.86
Actin isoforms in neuronal development and function. Int Rev Cell Mol Biol (2013) 0.85
Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actin. J Cell Sci (2011) 0.85
The carboxy-terminal third of dystrophin enhances actin binding activity. J Mol Biol (2011) 0.85
Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Neuromuscul Disord (2007) 0.85
Destabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscle. PLoS One (2008) 0.84
Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design. J Mol Biol (2012) 0.84
Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice. Skelet Muscle (2011) 0.82
Structural and functional properties of the actin gene family. Crit Rev Eukaryot Gene Expr (2011) 0.80